| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |